Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer

NCT00136539 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

41

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Herceptin
DRUG: Taxol
DRUG: Adriamycin
DRUG: Cytoxan

Sponsor

Harold J. Burstein, MD, PhD

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]